Cano Health, Inc. (NYSE:CANO – Get Rating)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $5.71, but opened at $6.06. Cano Health shares last traded at $6.62, with a volume of 217,543 shares traded.
Analyst Upgrades and Downgrades
Several equities analysts have commented on the stock. Raymond James assumed coverage on shares of Cano Health in a research report on Friday, June 24th. They set an “outperform” rating and a $8.00 target price on the stock. Piper Sandler lowered their target price on shares of Cano Health from $5.00 to $4.00 in a research report on Tuesday, May 10th. Cowen lowered their target price on shares of Cano Health from $13.00 to $10.00 in a research report on Tuesday, May 10th. Bank of America downgraded Cano Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $8.00 to $6.00 in a research report on Wednesday, June 15th. Finally, Citigroup lowered their price target on Cano Health from $10.00 to $8.00 in a research report on Tuesday, May 10th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $10.90.
Cano Health Trading Up 0.5 %
The firm has a market cap of $3.16 billion, a P/E ratio of -23.32 and a beta of 1.24. The company has a debt-to-equity ratio of 1.10, a current ratio of 2.04 and a quick ratio of 2.04. The company’s 50 day moving average is $5.32 and its two-hundred day moving average is $5.70.
Cano Health (NYSE:CANO – Get Rating) last announced its quarterly earnings results on Monday, May 9th. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.03. The firm had revenue of $704.34 million during the quarter, compared to analysts’ expectations of $676.10 million. Cano Health had a negative net margin of 0.55% and a negative return on equity of 6.66%. On average, sell-side analysts predict that Cano Health, Inc. will post -0.14 earnings per share for the current year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CANO. Ausdal Financial Partners Inc. bought a new position in shares of Cano Health in the fourth quarter valued at approximately $134,000. Discovery Capital Management LLC CT bought a new position in shares of Cano Health in the fourth quarter valued at approximately $2,406,000. Bayesian Capital Management LP bought a new position in shares of Cano Health in the fourth quarter valued at approximately $294,000. Massmutual Trust Co. FSB ADV bought a new position in shares of Cano Health in the first quarter valued at approximately $108,000. Finally, Gleason Group Inc. bought a new position in shares of Cano Health in the first quarter valued at approximately $41,000. Institutional investors own 37.64% of the company’s stock.
About Cano Health
Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.
Featured Stories
Receive News & Ratings for Cano Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Cano Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
